Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Gene Ther. 2021 Sep 28;29(10-11):601–607. doi: 10.1038/s41434-021-00294-2

Figure 2.

Figure 2.

Subretinal Bleb Propagation Duration and Rate. The total duration (A) and rate (B) for subretinal vector injection was recorded for 47 (67.1%) out of 70 subjects; the mean, median, and ranges for the total duration and rate of injections are provided in Table 1. The vector volumes ranged from 20 to 450 μL depending on the clinical trial specifications and the individualized target area. Publication of these vector volumes per condition are not included so as not to unmask the data associated with active clinical trials.